Table 3.
Time point | Study period | ||||||
---|---|---|---|---|---|---|---|
Screening | Visit 1 6–8 weeks pre-surgery |
Visit 2 1–2 weeks pre-surgery (intervention arm only) |
Visit 3 1 and 3 days pre-surgery |
Visit 4 Up to 5 days post-surgery |
Visit 5 6 weeks post-surgery |
Visit 6 6 months post intervention |
|
Enrolment: | |||||||
AUDIT C | X | ||||||
Expression of Interest | X | ||||||
Consent | X | ||||||
Randomisation | X | ||||||
Interventions: | |||||||
Intervention | X | ||||||
Booster | X | ||||||
TAU | X | ||||||
Assessments: | |||||||
AUDIT Baseline | X | ||||||
EQ-5D Baseline | X | ||||||
AUDIT Outcome | X | X | X | X | |||
EQ-5D Outcome | X | X | |||||
WOMAC | X | X | |||||
POMS | X | ||||||
Clavien-Dindo | X | ||||||
Interview | X |